Company Research Report: Hackensack Meridian Health
Company Overview
Name
Hackensack Meridian Health
Mission of the Company
Transform health care and be recognized as the leader of positive change.
Vision
Innovation is in our DNA, compelling us to create a world where: the highest quality care is human-centered, accessible and affordable; we deliver outcomes that matter most; and excellence is the standard. We believe in being creative, courageous, compassionate, collaborative, and connected.
When was the Company Founded and by Whom
No information is available
Key People in the Company
- Robert C. Garrett, FACHE, CEO of HMH
- Elizabeth A. Maiorana, MBA, MSN, R.N., VP, Cardiovascular Care Transformation Services
- Dr. Ihor Sawczuk, M.D., FACS, President of Academics, Research and Innovation
- Nitin Yerram, MD, Co-director of Urologic Oncology at JTCC
- Michael D. Stifelman, MD, Professor and Chair Urology, Hackensack Meridian School of Medicine
- Kenneth N. Sable, M.D., MBA, FACEP, Regional President, Southern Market
- Vito Buccellato, MPA, LNHA, President and Chief Hospital Executive, JSUMC
Where is the Company Headquartered
New Jersey, United States
Number of Employees
- More than 36,000 team members
- 7,000 physicians
Revenue of the Company
No information is available
What is the Company Known For
It is the largest, most comprehensive, and truly integrated health care network in New Jersey, offering a complete range of medical services, innovative research, and life-enhancing care.
Products and Services
What Products Do They Offer
- Comprehensive healthcare services covering cancer care, heart care, children's health, neurology & neurosurgery, orthopedic care, and behavioral health.
- Specialized centers including ambulatory care centers, surgery centers, and long-term care facilities among others.
- Advanced medical technologies and treatments like AI-based diagnostic tools, cardiovascular suites, and ECMO support.
High-Level Description of the Product
Hackensack Meridian Health offers an integrated healthcare network providing a suite of medical services and research-driven care aimed at patient-centric, innovative treatment options.
Key Features of Each of the Products
- Cardiovascular Suite: Offers advanced treatment space with increased patient capacity, featuring cardiac catheterization labs, EP labs, and hybrid operating rooms.
- Extracorporeal Membrane Oxygenation (ECMO): Provides advanced life support using a heart-lung machine to aid in cardio-respiratory failures.
- ArteraAI Prostate Test: AI-enabled technology for assessing prostate cancer aggressiveness post-surgery.
Recent Developments
What are the Recent Developments in the Company
- Opening of a new $45 million cardiovascular suite at Hackensack Meridian Jersey Shore University Medical Center.
- Recognition for excellence in life support care, achieving the Extracorporeal Life Support Organization's Gold Level Center of Excellence.
What are the New Products Launched
- Investment in the HYDROS Robotic System and the Intuitive Surgical da Vinci 5 multiport surgical system for advanced surgical treatments.
What are the New Features Added to the Existing Products
- Introduction of Artera’s multimodal AI platform to better predict prostate cancer outcomes.
- Enhanced platforms for minimally invasive interventional and electrophysiology procedures in new treatment spaces.
Any New Partnerships
- Collaboration with Artera in evaluating AI technology for prostate cancer diagnosis.
Conclusion
Hackensack Meridian Health continues to innovate and expand its comprehensive medical services with significant investments in technology and infrastructure, strengthened by awards and recognitions that affirm its leadership in healthcare excellence in New Jersey and beyond.
